Evidence map›Paper›PMID 35743943›Full record

ReviewLife (Basel, Switzerland)2022

Very-Low-Dose Radiation and Clinical Molecular Nuclear Medicine.

Chi-Jung Tsai, Kang-Wei Chang, Bang-Hung Yang, Ping-Hsiu Wu, Ko-Han Lin, Ching Yee Oliver Wong, Hsin-Lun Lee, Wen-Sheng Huang

Open access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Radiation issue in clinical nuclear molecular imaging.Journal of the Chinese Medical Association : JCMA · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Chi-Jung TsaiDepartment of Nuclear Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
Kang-Wei ChangTaipei Neuroscience Institute & Laboratory Animal Center, Taipei Medical University, Taipei 110, Taiwan.ORCID 0000-0002-4476-3603
Bang-Hung YangDepartment of Nuclear Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan.
Ping-Hsiu WuDepartment of Radiation Oncology, Taipei Medical University Hospital, Taipei 110, Taiwan.
Ko-Han LinDepartment of Nuclear Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan.
Ching Yee Oliver WongDepartment of Radiology, University of Southern California, Los Angeles, CA 90007, USA.
Hsin-Lun LeeDepartment of Radiation Oncology, Taipei Medical University Hospital, Taipei 110, Taiwan.
Wen-Sheng HuangDepartment of Nuclear Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
Taipei Medical University Hospital · TWTaipei Veterans General Hospital · TWTaipei Medical University · TWUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging molecular and precision medicine makes nuclear medicine a

Indexed as

nuclear medicineprotectionradiationradionuclidesriskstherapy

Identifiers

PMID35743943
PMCPMC9225609
OpenAlexW4283027680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.